Intervention
exosomes derived from human umbilical cord mesenchymal stem cells
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 2 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
2 shownExosome and Mesenchymal Stem Cell Treatment for Salivary Gland Dysfunction in Primary Sjögren SyndromeNCT07838454 · 2026-12-01
NOT_YET_RECRUITINGClinical Trial Investigating the Effect of Exosomes as a Complementary Treatment in Severe to Moderate Erectile DysfunctionNCT07319533 · 2026-01-01
NOT_YET_RECRUITINGCommon conditions
Erectile Dysfunction1Erectile Dysfunction Associated With Type 2 Diabetes Mellitus1Erectile Dysfunction Due to Arterial Disease1Erectile Dysfunction Due to Arterial Insufficiency1Erectile Dysfunction Due to General Medical Condition1Erectile Dysfunction Due to Neuropathy1Exosome1Sjogren Syndrome1Xerostomia1
Leading sponsors
Trial status mix
NOT_YET_RECRUITING2
Phase mix
PHASE22
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.